Prodia Secures $15M Seed Round to Revolutionize AI Inference Solutions

Prodia, a pioneer in distributed GPU networks for AI inference solutions, has announced a significant milestone with the closing of a $15 million seed funding round. This financing, led by Dragonfly Capital, underscores Prodia’s commitment to enhancing scalability and affordability in AI technologies through innovative Web3 infrastructure. Other notable investors include HashKey, Index Ventures, and…

Read More

Marea Therapeutics Secures $190 Million to Propel Novel Cardiovascular Treatments

Marea Therapeutics has marked a significant milestone with the successful closure of a $190 million combined Series A and B financing, positioning the clinical-stage biotechnology firm to accelerate its pioneering efforts in cardiometabolic disease treatments. Led by Third Rock Ventures and supported by a consortium of leading investors including Sofinnova Investments, Forbion, and Perceptive Xontogeny…

Read More

Albatross Secures €3M Funding to Transform User Engagement in eCommerce with Advanced AI-Driven Personalization Solutions

Swiss AI startup Albatross has announced a successful €3 million funding round, spearheaded by redalpine with additional participation from Daphni. Founded by former Amazon machine learning experts Dr. Kevin Kahn, Dr. Matteo Ruffini, and Johan Boissard, Albatross is set to redefine user engagement across eCommerce, media, and online marketplaces through innovative AI-driven personalization strategies. The…

Read More

Ancilia Biosciences Secures $4.2 Million in Financing to Advance CRISPR-Based Bacterial Therapies

Ancilia Biosciences, a pioneering biotechnology firm specializing in harnessing CRISPR technology for bacterial therapies, announced today the successful closure of an $4.2 million financing round. Safar Partners led the investment, joined by Metaplanet, Psymed Ventures, Zubi Capital, Spacecadet Ventures, and other institutional and private investors. The funding underscores the company’s commitment to leveraging CRISPR’s natural…

Read More